Multimodality Imaging of Aortic Valve Calcification and Function in a Murine Model of Calcific Aortic Valve Disease and Bicuspid Aortic Valve.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37321825.
- Also identified by DOI 10.2967/jnumed.123.265516 and PMC identifier 10478817.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Calcific aortic valve disease (CAVD) is a prevailing disease with increasing occurrence and no known medical therapy. <i>Dcbld2<sup>-/-</sup></i> mice have a high prevalence of bicuspid aortic valve (BAV), spontaneous aortic valve calcification, and aortic stenosis (AS). <sup>18</sup>F-NaF PET/CT can detect the aortic valve calcification process in humans. However, its feasibility in preclinical models of CAVD remains to be determined. Here, we sought to validate <sup>18</sup>F-NaF PET/CT for tracking murine aortic valve calcification and leveraged it to examine the development of calcification with aging and its interdependence with BAV and AS in <i>Dcbld2<sup>-/-</sup></i> mice. <b>Methods:</b> <i>Dcbld2<sup>-/-</sup></i> mice at 3-4 mo, 10-16 mo, and 18-24 mo underwent echocardiography, <sup>18</sup>F-NaF PET/CT (<i>n</i> = 34, or autoradiography (<i>n</i> = 45)), and tissue analysis. A subset of mice underwent both PET/CT and autoradiography (<i>n</i> = 12). The aortic valve signal was quantified as SUV<sub>max</sub> on PET/CT and as percentage injected dose per square centimeter on autoradiography. The valve tissue sections were analyzed by microscopy to identify tricuspid and bicuspid aortic valves. <b>Results:</b> The aortic valve <sup>18</sup>F-NaF signal on PET/CT was significantly higher at 18-24 mo (<i>P</i> < 0.0001) and 10-16 mo (<i>P</i> < 0.05) than at 3-4 mo. Additionally, at 18-24 mo BAV had a higher <sup>18</sup>F-NaF signal than tricuspid aortic valves (<i>P</i> < 0.05). These findings were confirmed by autoradiography, with BAV having significantly higher <sup>18</sup>F-NaF uptake in each age group. A significant correlation between PET and autoradiography data (Pearson <i>r</i> = 0.79, <i>P</i> < 0.01) established the accuracy of PET quantification. The rate of calcification with aging was significantly faster for BAV (<i>P</i> < 0.05). Transaortic valve flow velocity was significantly higher in animals with BAV at all ages. Finally, there was a significant correlation between transaortic valve flow velocity and aortic valve calcification by both PET/CT (<i>r</i> = 0.55, <i>P</i> < 0.001) and autoradiography (<i>r</i> = 0.45, <i>P</i> < 0.01). <b>Conclusion:</b> <sup>18</sup>F-NaF PET/CT links valvular calcification to BAV and aging in <i>Dcbld2<sup>-/-</sup></i> mice and suggests that AS may promote calcification. In addition to addressing the pathobiology of valvular calcification, <sup>18</sup>F-NaF PET/CT may be a valuable tool for evaluation of emerging therapeutic interventions in CAVD.
Medical subject headings
- Bicuspid Aortic Valve Disease
- Aortic Valve Stenosis